Jarrod Longcor, Chief Operating Officer at Cellectar Biosciences, Inc. (CLRB), bought 30,000 shares at $0.28 ($8K) on 2025-01-10, disclosed to the SEC on 2025-03-12.
Open-market purchase of $8k CLRB by Chief Operating Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| CLRB | BUY | 2020-12-28 | $40K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $150K | — | Filing → |
| CLRB | BUY | 2019-03-01 | $200 | — | Filing → |